PDLIM7 and nasopharyngeal carcinoma: After stimulation with this vaccine, activation and expansion of EBNA1- and LMP-specific CTL responses were observed in healthy donors and NPC patients, revealing the potential role of EBNA1- and LMP-based vaccine in NPC treatment.